Your browser doesn't support javascript.
loading
FMR1 mRNA from full mutation alleles is associated with ABC-CFX scores in males with fragile X syndrome.
Baker, Emma K; Arpone, Marta; Kraan, Claudine; Bui, Minh; Rogers, Carolyn; Field, Michael; Bretherton, Lesley; Ling, Ling; Ure, Alexandra; Cohen, Jonathan; Hunter, Matthew F; Santa María, Lorena; Faundes, Victor; Curotto, Bianca; Morales, Paulina; Trigo, Cesar; Salas, Isabel; Alliende, Angelica; Amor, David J; Godler, David E.
Afiliação
  • Baker EK; Diagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
  • Arpone M; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Kraan C; School of Psychology and Public Health, La Trobe University, Bundoora, VIC, Australia.
  • Bui M; Diagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
  • Rogers C; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Field M; Brain and Mind, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.
  • Bretherton L; Diagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
  • Ling L; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Ure A; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC, Australia.
  • Cohen J; Genetics of Learning Disability Service, Hunter Genetics, Hunter New England Health, Waratah, NSW, Australia.
  • Hunter MF; Genetics of Learning Disability Service, Hunter Genetics, Hunter New England Health, Waratah, NSW, Australia.
  • Santa María L; Diagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
  • Faundes V; Diagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
  • Curotto B; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Morales P; Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.
  • Trigo C; Royal Children's Hospital, Melbourne, VIC, Australia.
  • Salas I; Department of Pediatrics, Monash University, Clayton, VIC, Australia.
  • Alliende A; Fragile X Alliance Inc, North Caulfield, VIC, Australia.
  • Amor DJ; Centre for Developmental Disability Health Victoria, Monash University, Clayton, VIC, Australia.
  • Godler DE; Monash Genetics, Monash Health, Clayton, VIC, Australia.
Sci Rep ; 10(1): 11701, 2020 07 16.
Article em En | MEDLINE | ID: mdl-32678152
ABSTRACT
Fragile X syndrome (FXS) is caused by a hypermethylated full mutation (FM) expansion with ≥ 200 CGG repeats, and a decrease in FMR1 mRNA and its protein. However, incomplete silencing from FM alleles has been associated with more severe autism features in FXS males. This study compared scores on the Aberrant Behavior Checklist-Community-FXS version (ABC-CFX) in 62 males affected with FXS (3 to 32 years) stratified based on presence or absence of mosaicism and/or FMR1 mRNA silencing. Associations between ABC-CFX subscales and FMR1 mRNA levels, assessed using real-time PCR relative standard curve method, were also examined. The FXS group mosaic for premutation (PM 55-199 CGGs) and FM alleles had lower irritability (p = 0.014) and inappropriate speech (p < 0.001) scores compared to males with only FM alleles and complete loss of FMR1 mRNA. The PM/FM mosaic group also showed lower inappropriate speech scores compared to the incomplete silencing (p = 0.002) group. Increased FMR1 mRNA levels were associated with greater irritability (p < 0.001), and lower health-related quality of life scores (p = 0.004), but only in the incomplete silencing FM-only group. The findings suggest that stratification based on CGG sizing and FMR1 mRNA levels may be warranted in future research and clinical trials utilising ABC-CFX subscales as outcome measures.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / RNA Mensageiro / Alelos / Proteína do X Frágil da Deficiência Intelectual / Síndrome do Cromossomo X Frágil / Mosaicismo Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Male País/Região como assunto: America do sul / Chile / Oceania Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / RNA Mensageiro / Alelos / Proteína do X Frágil da Deficiência Intelectual / Síndrome do Cromossomo X Frágil / Mosaicismo Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Male País/Região como assunto: America do sul / Chile / Oceania Idioma: En Ano de publicação: 2020 Tipo de documento: Article